Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant

Completed · Phase 3

Conditions studied: VZV Infection After Bone Marrow Transplantation

In brief

The objective of this study is to prevent reactivation of herpes zoster during the first year after transplant.

Key facts

Study ID

NCT00209352

Run by

Fred Hutchinson Cancer Center

People needed

120

Starts

1985-06-01

Expected to finish

2004-07-01

Last updated by the study team

2007-12-21

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 10 years or older
• Both sex (male or female)
• Allogeneic transplant patient for hematologic malignancy or aplastic anemia

You may not qualify if…

• Previous intolerance to acyclovir
• Patients who are unavailable for follow-up
• Patients in whom drug compliance may be a problem
• Evidence of active VZV infection
• VZV infection in the initial 1 month after transplant
• Pregnant women, lactating women, or those not using adequate contraception
• Creatinine > 3.0 mg/dl.

Where it is running

• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.